FDA.reportPublic FDA data

ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW)

Substance profile for UNII P2OM2Q86BI, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#

UNII
P2OM2Q86BI
Preferred term
ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW)
Registry number
9010-88-2
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
Polymer substance not supported

Chemical And Database Identifiers#

RxCUI
1426457
PubChem
0
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
RxNorm1426457mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1426457
FDA Substance Registration SystemP2OM2Q86BIprecision.fda.gov/uniisearch/srs/unii/P2OM2Q86BI

DailyMed Socrata Ingredients#

DailyMed label, SPL version table
DailyMed labelSPL version
Tramadol Hydrochloride1
TRAMADOL HYDROCHLORIDE3
Venlafaxine Hydrochloride Extended-release Capsules, USP4
Venlafaxine Hydrochloride Extended-release Capsules1
These highlights do not include all the information needed to use Tramadol Hydrochloride Extended-Release safely and effectively. See full prescribing information for Tramadol Hydrochloride Extended-Release. Tramadol Hydrochloride Extended-Release (tramadol hydrochloride) Extended-Release Capsules Initial U.S. Approval: 19951
These highlights do not include all the information needed to use Tramadol Hydrochloride Extended-Release safely and effectively. See full prescribing information for Tramadol Hydrochloride Extended-Release. Tramadol Hydrochloride Extended-Release (tramadol hydrochloride) Extended-Release Capsules Initial U.S. Approval: 19952
TRAMADOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK]1002
TAZTIA XT (DILTIAZEM HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [WATSON PHARMA, INC.]13
NAPROXEN SODIUM TABLET, FILM COATED, EXTENDED RELEASE [ACTAVIS PHARMA, INC.]7
CARDIZEM LA (DILTIAZEM HYDROCHLORIDE) TABLET, EXTENDED RELEASE [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]6
TAMSULOSIN HYDROCHLORIDE CAPSULE [SANDOZ INC]6
VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [ZYDUS PHARMACEUTICALS (USA) INC.]6
CARDIZEM LA (DILTIAZEM HYDROCHLORIDE) TABLET, EXTENDED RELEASE [ABBVIE INC.]4
TRAMADOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [UNIT DOSE SERVICES]4
CONZIP (TRAMADOL HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [VERTICAL PHARMACEUTICALS, LLC]3
DILTIAZEM HYDROCHLORIDE EXTENDED RELEASE (DILTIAZEM HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [OCEANSIDE PHARMACEUTICALS]3
DILTZAC (DILTIAZEM HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [APOTEX CORP.]3
TRAMADOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3
TRAMADOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [PROFICIENT RX LP]3
VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [GOLDEN STATE MEDICAL SUPPLY, INC]3
CONZIP (TRAMADOL HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [VERTICAL PHARMACEUTICALS INC.]2
TAMSULOSIN HYDROCHLORIDE CAPSULE [MAJOR PHARMACEUTICALS]2
TAZTIA XT (DILTIAZEM HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [AMERICAN HEALTH PACKAGING]2
TRAMADOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [PREFERRED PHARMACEUTICALS, INC.]2
TRAMADOL HYDROCHLORIDE EXTENDED-RELEASE (TRAMADOL HYDROCHLORIDE) CAPSULE [TRIGEN LABORATORIES, LLC]2
VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [CADILA HEALTHCARE LIMITED]2
DILTIAZEM HYDROCHLORIDE (DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS) TABLET, EXTENDED RELEASE [OCEANSIDE PHARMACEUTICALS]1
TIAZAC EXTENDED RELEASE (DILTIAZEM HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]1
TRAMADOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [A-S MEDICATION SOLUTIONS LLC]1
TRAMADOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [A-S MEDICATION SOLUTIONS LLC]1
TRAMADOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [MEDSOURCE PHARMACEUTICALS]1
TRAMADOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [PREFERRED PHARMACEUTICALS INC.]1
TRAMADOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [STA3, LLC]1
TRAMADOL HYDROCHLORIDE EXTENDED RELEASE (TRAMADOL HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [GALEPHAR PHARMACEUTICAL RESEARCH INC.]1
VENLAFAXINE HYDROCHLORIDE CAPSULE, COATED, EXTENDED RELEASE [DIRECT RX]1
VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]1

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII P2OM2Q86BI page 1 of 1 · 7 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW)P2OM2Q86BI9010882CAPSULE, COATED PELLETSORAL93.36 mg
ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW)P2OM2Q86BI9010882CAPSULE, EXTENDED RELEASEORAL187.3 mg
ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW)P2OM2Q86BI9010882GRANULEORAL274 mg
ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW)P2OM2Q86BI9010882TABLETORAL25 mg
ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW)P2OM2Q86BI9010882TABLET, COATEDORAL66 mg
ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW)P2OM2Q86BI9010882TABLET, EXTENDED RELEASEORAL96.5 mg
ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW)P2OM2Q86BI9010882TABLET, FILM COATED, EXTENDED RELEASEORAL30 mg